Results 281 to 290 of about 444,049 (319)

Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next‐Generation Approaches

open access: yesAdvanced Science, EarlyView.
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey   +6 more
wiley   +1 more source

Pro-Inflammatory Activation Promotes Atherogenic Endothelial Phenotype in Male and Female Human Umbilical Endothelial Vein Cells (HUVECs). [PDF]

open access: yesInt J Mol Sci
Lorenz M   +14 more
europepmc   +1 more source

Advances in Surface Biofunctionalization and Intelligent Monitoring of Vascular Scaffolds. [PDF]

open access: yesResearch (Wash D C)
Rafique M   +5 more
europepmc   +1 more source

Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases

Vasa - European Journal of Vascular Medicine, 2022
Vascular adhesion protein-1 (VAP-1) also known as amino oxidase copper containing 3 (AOC3) is a pro-inflammatory and versatile molecule with adhesive and enzymatic properties. VAP-1 is a primary amine oxidase belonging to the semicarbazide-sensitive amine oxidase (SSAO) family, which catalyzes the oxidation of primary amines leading to the production ...
Marianna Danielli   +2 more
exaly   +4 more sources

Vascular adhesion protein-1 and microvascular diabetic complications

Pharmacological Reports, 2022
Vascular adhesion protein-1 (VAP-1) is a bifunctional protein that has the ability to catalyze the deamination of primary amines and is involved in the production of hydrogen peroxide, aldehydes, and advanced glycation end products (AGEs). VAP-1 is usually stored in intracellular vesicles of endothelial cells, smooth muscles, and adipocytes.
Alok D. Singh, Yogesh A. Kulkarni
openaire   +2 more sources

Expression of Vascular Adhesion Protein-1 in Atopic Eczema

International Archives of Allergy and Immunology, 2006
<i>Background:</i>Vascular adhesion protein-1 (VAP-1) is an adhesion molecule with an enzymatic activity which partakes in the migration process of lymphocytes. The aim of this study was to investigate VAP-1 expression in atopic eczema (AE) in comparison with healthy controls and psoriatic individuals.
Aneta, Madej   +3 more
openaire   +3 more sources

Vascular adhesion protein‐1 and syndecan‐1 in septic shock

Acta Anaesthesiologica Scandinavica, 2011
BackgroundConstituents of vascular endothelial surface layer (glycocalyx), e.g. an anchor protein syndecan‐1 (SDC‐1), can be detected in plasma in many inflammatory conditions. In inflammation, vascular adhesion protein‐1 (VAP‐1) is rapidly translocated to the apical side of the endothelial cells and may be released to plasma in a soluble form.
Pettilä Ville   +4 more
openaire   +2 more sources

Lymphocyte Trafficking Mediated by Vascular Adhesion Protein-1 [PDF]

open access: yesCirculation Research, 2000
The trafficking, extravasation, and retention of lymphocytes within certain tissues (eg, lymph nodes) seem to be mediated by several classes of specialized adhesion glycoproteins that are expressed on the surface of unique endothelial cells (high endothelial venules [HEVs]) that exist in both the blood and lymph microvessels.1 2 The binding of these ...
J Steve Alexander, D Neil Granger
exaly   +2 more sources

Home - About - Disclaimer - Privacy